Latest News & Updates
Breaking News
3 hours ago
Simantini Singh Deo
Other trending news you may like to read
BPGbio Appoints John Dvor As Executive Vice President Of Corporate Development To Drive Strategic Growth And Partnerships
BPGbio appoints John Dvor as EVP of Corporate Development to drive growth, partnerships, and commercialization of its AI-driven biopharma programs.
Simantini Singh Deo
Quoin Pharmaceuticals Reaches Key Milestone With 4% Topical And 5% Patch Rapamycin Formulations, Paving Way For Clinical Trials In Rare Dermatological And Vascular Disorders
Quoin Pharmaceuticals achieves key milestone with 4% and 5% topical rapamycin formulations, advancing treatments for rare skin and vascular diseases.
Simantini Singh Deo
Ariceum Therapeutics Doses First Patient In SANTANA-225 Phase 1/2 Trial Of 225Ac-SSO110 For Extensive Stage Small Cell Lung Cancer And Merkel Cell Carcinoma
Ariceum starts Phase 1/2 SANTANA-225 trial of 225Ac-SSO110, targeting SSTR2 in small cell lung and Merkel cell cancers.
Simantini Singh Deo
March Biosciences’ MB-105 CAR-T Therapy Receives FDA RMAT Designation For Relapsed Or Refractory CD5-Positive T-Cell Lymphoma
March Biosciences receives FDA RMAT designation for MB-105, its first-in-class CD5-targeted CAR-T therapy for relapsed or refractory T-cell lymphoma, supporting accelerated development.
Simantini Singh Deo
